Anatomic Pathology Market Size & Share, by Type (Services, Consumables, Instruments); Subdivision (Histopathology, Cytopathology); Application (Disease Diagnosis, Drug Discovery & Development); End-user (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4377
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Anatomic Pathology Landscape

top-features-companies
    • PHC Holdings Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Indica Labs, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Sakura Finetek USA, Inc.
    • Cardinal Health, Inc.
    • BioGenex
    • NeoGenomics Laboratories, Inc.
    • Agilent Technologies, Inc. 

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Epredia, - a subsidiary of PHC Holdings Corporation announced that its parent company has acquired anatomical pathology suppliers Laurypath and Microm Microtech France (MMFrance) to mark strategic expansion of Epredia’s presence in Europe.

  •  Indica Labs, Inc., - with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics(iCAIRD), announced an agreement to collaborate on the development of an AI-based digital pathology solution. The pathology will assist the detection of cancer within lymph nodes from colorectal surgery cases.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4377
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing number of laboratory tests as well as biopsies performed along with rising cases of cancer, kidney diseases and others are some of the major factors anticipated to drive the growth of the market.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2033.

High expenditure associated in developing anatomic pathology as well as non-availability of refurbished anatomic pathology equipment are some of the factors estimated to hamper the market growth.

The market in North America, with the current highest market share of 39.21% is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are PHC Holdings Corporation, Indica Labs, Inc., Laboratory Corporation of America Holdings, F.Hoffmann-La Roche AG, Quest Diagnostics Incorporated, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, subdivision, application, end-user, and by region.

The services segment - 48.12% holds the largest market share in 2022.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying